Panniculitis does not predict clinical response in patients with advanced melanoma under targeted therapy

• Published in: EJD. European journal of dermatology Vol. 33; no. 2; pp. 126 - 136
• Main Authors: Piroth, Marie, Goronflot, Thomas, Samaran, Romain, Varey, Emilie, Poinas, Alexandra, Khammari, Amir, Dreno, Brigitte
• Format: Journal Article
• Language: English
• Published: Paris John Libbey Eurotext 01.04.2023
• Subjects: Adolescent; Arthralgia; Clinical Report; Dermatology; Female; Humans; Life Sciences; Male; Medicine; Medicine & Public Health; Melanoma - drug therapy; Panniculitis - chemically induced; Remission, Spontaneous; Retrospective Studies; targeted therapy; BRAF inhibitor; melanoma; panniculitis; MEK inhibitor; oncology

Background BRAF and MEK inhibitors have changed the landscape of treatment for advanced melanoma. Among their side effects, panniculitis has been hypothesized to be associated with better survival. Objectives In this study, we aimed to explore the association between the occurrence of panniculitis d...